Cocrystal Pharma Statistics
Total Valuation
COCP has a market cap or net worth of $23.91 million. The enterprise value is $3.77 million.
| Market Cap | 23.91M |
| Enterprise Value | 3.77M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
COCP has 10.17 million shares outstanding. The number of shares has increased by 24.94% in one year.
| Shares Outstanding | 10.17M |
| Shares Change (YoY) | +24.94% |
| Shares Change (QoQ) | -0.46% |
| Owned by Insiders (%) | 30.03% |
| Owned by Institutions (%) | 7.09% |
| Float | 7.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.06 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.30, with a Debt / Equity ratio of 0.08.
| Current Ratio | 10.30 |
| Quick Ratio | n/a |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.48 |
Financial Efficiency
Return on equity (ROE) is -58.60% and return on invested capital (ROIC) is -72.14%.
| Return on Equity (ROE) | -58.60% |
| Return on Assets (ROA) | -52.90% |
| Return on Capital (ROIC) | -72.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.40M |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.23% in the last 52 weeks. The beta is 1.41, so COCP's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | -14.23% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 1.80 |
| Relative Strength Index (RSI) | 51.36 |
| Average Volume (20 Days) | 26,966 |
Short Selling Information
The latest short interest is 18,063, so 0.18% of the outstanding shares have been sold short.
| Short Interest | 18,063 |
| Short Previous Month | 6,054 |
| Short % of Shares Out | 0.18% |
| Short % of Float | 0.25% |
| Short Ratio (days to cover) | 0.46 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.61M |
| Pretax Income | -16.75M |
| Net Income | -16.75M |
| EBITDA | -15.77M |
| EBIT | -15.89M |
| Earnings Per Share (EPS) | -$1.65 |
Balance Sheet
The company has $21.96 million in cash and $1.82 million in debt, giving a net cash position of $20.14 million or $1.98 per share.
| Cash & Cash Equivalents | 21.96M |
| Total Debt | 1.82M |
| Net Cash | 20.14M |
| Net Cash Per Share | $1.98 |
| Equity (Book Value) | 22.59M |
| Book Value Per Share | 2.22 |
| Working Capital | 22.11M |
Cash Flow
In the last 12 months, operating cash flow was -$16.06 million and capital expenditures -$81,000, giving a free cash flow of -$16.14 million.
| Operating Cash Flow | -16.06M |
| Capital Expenditures | -81,000 |
| Free Cash Flow | -16.14M |
| FCF Per Share | -$1.59 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COCP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.94% |
| Shareholder Yield | -24.94% |
| Earnings Yield | -70.06% |
| FCF Yield | -67.50% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 11, 2022. It was a reverse split with a ratio of 1:12.
| Last Split Date | Oct 11, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |